1YR企业会员
| 英文名称 | 中文名称 | CAS |
|---|---|---|
| Fmoc-MMAE | (9H-芴-9-基)甲基 ((S)-1-(((S)-1-(((3R,4S,5S)-1-((S)-2-((1R,2R)-3-(((1S,2R)-1-羟基-1-苯基丙烷-2-基)氨基)-1-甲氧基-2-甲基-3-氧代丙基)吡咯烷-1-基)-3-甲氧基-5-甲基-1-氧代庚烷-4-基)(甲基)氨基)-3-甲基-1-氧代丁烷-2-基)氨基)-3-甲基-1-氧代丁烷-2-基)(甲基)氨基甲酸酯 | 474645-26-6 |
| COOtBu-PEG8-C2-NH2 | 1-氨基-3,6,9,12,15,18,21,24-八氧杂二十七烷基-27-酸叔丁酯 | 756526-06-4 |
| Boc:ValCitPAB-OH | ((S)-1-(((S)-1-((4-(羟甲基)苯基)氨基)-1-氧代-5-脲基戊-2-基)氨基)-3-甲基-1-氧代丁-2-基)氨基甲酸叔丁酯 | 870487-09-5 |
| Mal-amido-PEG8-COOtBu | 马来酰亚胺-酰胺-八聚乙二醇-丙酸叔丁酯 | 2864817-39-8 |
| N-Methoxycarbonylmaleimide | 2,5-二氧代-2,5-二氢-1H-吡咯-1-羧酸甲酯 | 55750-48-6 |
| Monomethyl auristatin E | (S)-N-((3R,4S,5S)-1-((S)-2-((1R,2R)-3-(((1S,2R)-1-羟基-1-苯基丙烷-2-基)氨基)-1-甲氧基-2-甲基-3-氧代丙基)吡咯烷-1-基)-3-甲氧基-5-甲基-1-氧代庚烷-4-基)-N,3-二甲基-2-((S)-3-甲基-2-(甲基氨基)丁酰胺基)丁酰胺 | 474645-27-7 |
| Fmoc-Val-Cit-PAB-PNP | (9H-芴-9-基)甲基 ((S)-3-甲基-1-(((S)-1-((4-((((4-硝基苯氧基)羰基)氧基)甲基)苯基)氨基)-1-氧代-5-脲基戊-2-基)氨基)-1-氧代丁-2-基)氨基甲酸酯 | 863971-53-3 |
| 4-Hydroxy-thalidomide | 2-(2,6-二氧代哌啶-3-基)-4-羟基异吲哚啉-1,3-二酮 | 5054-59-1 |
| Pomalidomide | 4-氨基-2-(2,6-二氧代哌啶-3-基)异吲哚-1,3-二酮 | 19171-19-8 |
| Thalidomide-O-PEG4-acid | 1-((2-(2,6-二氧代哌啶-3-基)-1,3-二氧代异吲哚啉-4-基)氧基)-2-氧代-6,9,12,15-四氧杂-3-氮杂十八烷-18-酸 | 2353563-50-3 |
| Thalidomide-O-PEG4-NHS ester | 2,5-二氧代吡咯烷-1-基1-((2-(2,6-二氧代哌啶-3-基)-1,3-二氧代异吲哚啉-4-基)氧基)-3,6,9,12-四氧杂十五烷-15-酸酯 | 2411681-88-2 |
| Thalidomide-O-PEG4-t-butyl ester | 萨力多胺-O-四聚乙二醇-叔丁酯;沙利度胺-O-四聚乙二醇-叔丁酯 | 2411681-87-1 |
| Thalidomide-O-PEG4-azide | 萨力多胺-O-四聚乙二醇-叠氮;沙利度胺-O-四聚乙二醇-叠氮 | 2380318-57-8 |
| Thalidomide-O-amido-PEG4-azide | 沙利度胺-O-酰胺-四聚乙二醇-叠氮 | 2411681-89-3 |
| Thalidomide-O-PEG4-propargyl | 4-((3,6,9,12-四氧杂十五碳-14-炔-1-基)氧基)-2-(2,6-二氧代哌啶-3-基)异吲哚啉-1,3-二酮 | 2098799-77-8 |
| Pomalidomide-PEG4-azide | 4-((14-叠氮-3,6,9,12-四氧杂十四烷基)氨基)-2-(2,6-二氧代哌啶-3-基)异吲哚啉-1,3-二酮 | 2271036-47-4 |
| Thalidomide-O-PEG4-amine | 4-((14-氨基-3,6,9,12-四氧杂十四烷基)氧基)-2-(2,6-二氧代哌啶-3-基)异吲哚啉-1,3-二酮 | 2401832-00-4 |
| Amino-PEG2-Acetic Acid | 2-(2-(2-氨基乙氧基)乙氧基)乙酸 | 134978-97-5 |
| Pomalidomide-PEG4-Ph-NH2 | 4-((2-(2-(2-(2-(4-氨基苯氧基)乙氧基)乙氧基)乙氧基)乙基)氨基)-2-(2,6-二氧代哌啶-3-基)异吲哚啉-1,3-二酮 | 1818885-63-0 |
| Bis-PEG6-Acid | 4,7,10,13,16,19-六氧杂二十二烷二酸 | 119189-70-7 |
| (S,R,S)-AHPC hydrochloride | (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 | 1448189-80-7 |
| Propargyl-PEG5-amine | 3,6,9,12,15-五氧杂十八烷-17-炔-1-胺 | 1589522-46-2 |
| Propargyl-PEG6-Propionic Acid | 4,7,10,13,16,19-六氧杂二十二烷-21-炔酸 | 1951438-84-8 |
| Azido-PEG4-Propionic Acid | Azido-PEG4-羧酸 | 1257063-35-6 |
| Azido-PEG3-Acetic Acid | N3-PEG3-CH2COOH | 172531-37-2 |
| Azido-PEG3-Alcohol | 2-(2-(2-叠氮基乙氧基)乙氧基)乙醇 | 86520-52-7 |
| Amino-PEG4-Alcohol | 2-(2-(2-(2-氨基乙氧基)乙氧基)乙醇 | 86770-74-3 |
| Amino-PEG4-Acetic Acid | 14-氨基-3,6,9,12-四氧杂十四烷-1-酸 | 195071-49-9 |
| Amino-PEG3-Acetic Acid | 2-(2-(2-(2-氨基乙氧基)乙氧基)乙氧基)乙酸 | 134978-99-7 |
| Amino-PEG4-Propionic Acid | 1-氨基-3,6,9,12-四氧杂十五烷-15-酸 | 663921-15-1 |
| Amino-PEG3-Propionic Acid | 3-[2-[2-(2-氨基乙氧基)乙氧基]乙氧基]丙酸 | 784105-33-5 |
| Amino-PEG2-Propionic Acid | 3-[2-(2-氨基乙氧基)乙氧基]-丙酸 | 791028-27-8 |
| (S,R,S)-AHPC-PEG4-acid | (S)-18-((2S,4R)-4-羟基-2-((4-(4-甲基噻唑-5-基)苄基)氨基甲酰基)吡咯烷-1-羰基)-19,19-二甲基-16-氧代-4,7,10,13-四氧杂-17-氮杂二十烷酸 | 2172820-12-9 |
| (S,R,S)-AHPC-PEG2-acid | 3-(2-(3-(((S)-1-((2S,4R)-4-羟基-2-((4-(4-甲基噻唑-5-基)苄基)氨基甲酰基)吡咯烷-1-基)-3,3-二甲基-1-氧代丁烷-2-基)氨基)-3-氧代丙氧基)乙氧基)丙酸 | 2172820-09-4 |
| 2245697-87-2 | ||
| MC-Val-Cit-PAB | N-[6-(2,5-二氢-2,5-二氧代-1H-吡咯-1-基)-1-氧代己基]-L-缬氨酰-N5-(氨基甲酰基)-N-[4-(羟甲基)苯基]-L-鸟氨酰胺 | 159857-80-4 |
| Fmoc-Val-Cit-PAB-OH | ((S)-1-(((S)-1-((4-(羟甲基)苯基)氨基)-1-氧代-5-脲基戊烷-2-基)氨基)-3-甲基-1-氧代丁烷-2-基)氨基甲酸 (9H-芴-9-基)甲酯 | 159858-22-7 |
| Mal-PEG2-acid | 马来酰亚胺-二聚乙二醇-羧酸 | 1374666-32-6 |
| Dap-NE | (2R,3R)-N-((1S,2R)-1-羟基-1-苯基丙-2-基)-3-甲氧基-2-甲基-3-((S)-吡咯烷-2-基)丙酰胺 | 160800-82-8 |
| Thalidomide-piperazine HCl;2-(2,6-Dioxopiperidin-3-yl)-5-(piperazin-1-yl)isoindoline-1,3-dione hydrochloride | 2-(2,6-二氧代哌啶-3-基)-5-(哌嗪-1-基)异吲哚啉-1,3-二酮盐酸盐 | 2228029-82-9 |
| 1-(2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)piperidine-4-carboxylic acid | 1-(2-(2,6-二氧代哌啶-3-基)-1,3-二氧代异吲哚啉-5-基)哌啶-4-甲酸 | 2467965-70-2 |
| Pomalidomide-PEG1-NH2 HCl | 2-(2-氨基乙氧基)-N-(2-(2,6-二氧代哌啶-3-基)-1,3-二氧代异吲哚啉-4-基)乙酰胺盐酸盐 | 2380273-67-4 |
| Thalidomide-O-amido-PEG4-C2-NH2 HC | N-(14-氨基-3,6,9,12-四氧杂十四烷基)-2-((2-(2,6-二氧代哌啶-3-基)-1,3-二氧代异吲哚啉-4-基)氧基)乙酰胺盐酸盐 | 2245697-85-0 |
| Pomalidomide-PEG2-COOH | 3-(2-(2-((2-(2,6-二氧代哌啶-3-基)-1,3-二氧代异吲哚啉-4-基)氨基)乙氧基)乙氧基)丙酸 | 2140807-17-4 |
| 4-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)butanoic acid | 4-((2-(2,6-二氧代哌啶-3-基)-1,3-二氧代异吲哚啉-4-基)氨基)丁酸 | 2225940-47-4 |
| Boc-Gly-Gly-Gly-OH | Boc-甘氨酸-甘氨酸-甘氨酸 | 28320-73-2 |
| (S)-2-((S)-2-(6-(2,5-Dioxo-2H-pyrrol-1(5H)-yl)hexanamido)-3-methylbutanamido)propanoic acid | (S)-2-((S)-2-(6-(2,5-二氧代-2H-吡咯-1(5H)-基)己酰胺基)-3-甲基丁酰氨基)丙酸 | 1342211-31-7 |
| 3-(Maleimidopropane-1-carbonyl-1-(tert-butyl)carbazate | 2-(3-(2,5-二氧代-2,5-二氢-1H-吡咯-1-基)丙酰基)肼羧酸叔丁酯 | 1076198-38-3 |
| (S)-2-((S)-2-((S)-2-Aminopropanamido)propanamido)-N1-(4-(hydroxymethyl)phenyl)succinamide | (S)-2-((S)-2-((S)-2-氨基丙酰胺基)丙酰胺基)-N1-(4-(羟甲基)苯基)丁二酰胺 | 2149584-00-7 |
| Pomalidomide-C6-COOH | 7-((2-(2,6-二氧代哌啶-3-基)-1,3-二氧代异吲哚啉-4-基)氨基)庚酸 | 2225940-50-9 |
| Fmoc-Val-Ala-OH | (S)-2-((S)-2-((((9H-芴-9-基)甲氧基)羰基)氨基)-3-甲基丁酰胺基)丙酸 | 150114-97-9 |
| Thalidomide-NH-CH2-COOH | 2-((2-(2,6-二氧代哌啶-3-基)-1,3-二氧代异吲哚啉-4-基)氨基)乙酸( | 927670-97-1 |
| Thalidomide-4-O-C2-NH2 HCl | 4-(2-氨基乙氧基)-2-(2,6-二氧代哌啶-3-基)异吲哚啉-1,3-二酮盐酸盐 | 2341840-99-9 |
| Mal-PEG8-acid | 1-(2,5-二氧代-2,5-二氢-1H-吡咯-1-基)-3,6,9,12,15,18,21,24-八氧杂二十七烷-27-酸 | 1818294-46-0 |
| tert-Butyl (5S,8S,11S,12R)-11-((S)-sec-butyl)-1-(9H-fluoren-9-yl)-5,8-diisopropyl-12-methoxy-4,10-dimethyl-3,6,9-trioxo-2-oxa-4,7,10-triazatetradecan-14-oate | (5S,8S,11S,12R)-11-((S)-仲丁基)-1-(9H-芴-9-基)-5,8-二异丙基-12-甲氧基-4,10 -二甲基-3,6,9-三氧代-2-氧杂-4,7,10-三氮杂十四烷-14-酸叔丁酯 | 474645-25-5 |
| Pomalidomide-PEG6-butyl iodide | N-(2-(2,6-二氧代哌啶-3-基)-1,3-二氧代异吲哚啉-4-基)-24-碘-3,6,9,12,15,18-六氧代二十四烷-1-酰胺 | 1835705-74-2 |
| (S,R,S)-AHPC-PEG6-C4-Cl | (S,R,S)-AHPC-2-2-2-2-2-2-6-氯 | 1835705-59-3 |
| Thalidomide-O-amido-C4-NH2 | N-(4-氨基丁基)-2-((2-(2,6-二氧代哌啶-3-基)-1,3-二氧异吲哚啉-4-基)氧基)乙酰胺 | 1799711-24-2 |
| Thalidomide-O-amido-C3-NH2 | N-(3-氨基丙基)-2-((2-(2,6-氧代哌啶-3-基)-1,3-二氧代异吲哚啉-4-基)氧基)乙酰胺 | 2022182-57-4 |
| Thalidomide-O-amido-PEG3-C2-NH2 TFA | N-(2-(2-(2-(2-氨基乙氧基)乙氧基)乙氧基)乙基)-2-((2-(2,6-二氧代哌啶-3-基)-1,3-二氧代异吲哚啉-4-基)氧基)乙酰胺 三氟乙酸盐 | 1957236-21-3 |
| Thalidomide-O-amido-C4-NH2 TFA | N-(4-氨基丁基)-2-((2-(2,6-二氧代哌啶-3-基)-1,3-二氧代异吲哚啉-4-基)氧基)乙酰胺 2,2,2-三氟乙酸盐 | 1799711-25-3 |
| Pomalidomide-C6-PEG3-Butyl Iodide | N-(2-(2,6-二氧代哌啶-3-基)-1,3-二氧代异吲哚啉-4-基)-6-(2-(2-((6-碘己基)氧基)乙氧基)乙氧基)己酰胺 | 1835705-70-8 |
| (S,R,S)-AHPC-C6-PEG3-C4-Cl | S,R,S)-AHPC-C6-PEG3-丁基氯 | 1835705-55-9 |
| (S,R,S)-AHPC-PEG4-NH2 | (2S,4R)-1-((S)-17-氨基-2-(叔丁基)-4-氧代-6,9,12,15-四氧杂-3-氮杂十七烷-1-酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺 | 2010159-57-4 |
| (S,R,S)-AHPC-PEG2-NH2 | (2S,4R)-1-((S)-2-(2-(2-(2-氨基乙氧基)乙氧基)乙酰氨基)-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺 | 2010159-60-9 |
| Thalidomide-O-amido-PEG2-C2-NH2 TFA | Thalidomide-O-amido-PEG2-C2-Amine Trifluoroacetate | 1957235-75-4 |
| (S,R,S)-AHPC-PEG3-NH2 | (2S,4R)-1-((S)-14-氨基-2-(叔丁基)-4-氧代-6,9,12-三氧杂-3-氮杂十四烷-1-酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺 | 2010159-56-3 |
| Thalidomide-O-amido-PEG4-C2-NH2 | N-(14-氨基-3,6,9,12-四氧杂十四烷基)-2-((2-(2,6-二氧代哌啶-3-基)-1,3-二氧代异吲哚啉-4-基)氧基)乙酰胺 | 1957236-22-4 |
| Pomalidomide-PEG4-C2-NH2 | 4-((14-氨基-3,6,9,12-四氧杂十四烷基)氨基)-2-(2,6-二氧代哌啶-3-基)异吲哚啉-1,3-二酮 | 2225940-52-1 |
| Thalidomide-O-amido-PEG3-C2-NH2 | N-(2-(2-(2-(2-氨基乙氧基)乙氧基)乙氧基)乙基)-2-((2-(2,6-二氧代哌啶-3-基)-1,3-二氧代异吲哚啉-4-基)氧基)乙酰胺 | 1957236-20-2 |
| VH 032 amide-alkylC2-acid | 4-(((S)-1-((2S,4R)-4-羟基-2-((4-(4-甲基噻唑-5-基)苄基)氨基甲酰基)吡咯烷-1-基)-3,3-二甲基-1-氧代丁烷-2-基)氨基)-4-氧代丁酸 | 2172819-72-4 |
| Thalidomide-4-O-C6-NH2 | 4-((6-氨基己基)氧基)-2-(2,6-二氧代哌啶-3-基)异吲哚啉-1,3-二酮 | 1957235-98-1 |
| Thalidomide-PEG3-NH2 | 4-(2-(2-(-2-氨基乙氧基)乙氧基)乙氧基)-2-(2,6-二氧代哌啶-3-基)异吲哚啉-1,3-二酮 | 1957236-10-0 |
| (S,R,S)-AHPC-C7-amine | (2S,4R)-1-((S)-2-(8-氨基辛酰胺基)-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺 | 2306389-04-6 |
| Thalidomide-O-amide-C5-NH2 | N-(5-氨基戊基)-2-((2-(2,6-二氧代哌啶-3-基)-1,3-二氧代异吲哚啉-4-基)氧基)乙酰胺 | 2360527-40-6 |
| (S,R,S)-AHPC-C4-NH2 2HCl | (2S,4R)-1-((S)-2-(5-氨基戊酰胺)-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺二盐酸盐 | 2341796-78-7 |
| Thalidomide-O-PEG2-NHS ester | 2,5-二氧代吡咯烷-1-基 3-(2-(2-((2-(2,6-二氧代哌啶-3-基)-1,3-二氧代异吲哚啉-4-基)氧基)乙氧基)乙氧基)丙酸酯 | 2639395-34-7 |
| VH 032 amide-alkylC8-acid | 10-(((S)-1-((2S,4R)-4-羟基-2-((4-(4-甲基噻唑-5-基)苄基)氨基甲酰基)吡咯烷-1-基)-3,3-二甲基-1-氧代丁-2-基)氨基)-10-氧代癸酸 | 2172819-77-9 |
| (S,R,S)-AHPC-amido-C6-acid | 8-(((S)-1-((2S,4R)-4-羟基-2-((4-(4-甲基噻唑-5-基)苄基)氨基甲酰基)吡咯烷-1-基)-3,3-二甲基-1-氧代丁烷-2-基)氨基)-8-氧代辛酸 | 2172819-75-7 |
| 4-((20-Amino-3,6,9,12,15,18-hexaoxaicosyl)amino)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione | 4-((20-氨基-3,6,9,12,15,18-六氧杂二十烷基)氨基)-2-(2,6-二氧代哌啶-3-基)异吲哚啉-1,3-二酮 | 2414292-69-4 |
| (S,R,S)-AHPC-amido-C7-acid | 9-(((S)-1-((2S,4R)-4-羟基-2-((4-(4-甲基噻唑-5-基)苄基)氨基甲酰基)吡咯烷-1-基)-3,3-二甲基-1-氧代丁烷-2-基)氨基)-9-氧代壬酸 | 2172819-76-8 |
| Pomalidomide-C7-NH2 HPomalidomide-C7-NH2 HClCl | 4-((7-氨基庚基)氨基)-2-(2,6-二4-((7-氨基庚基)氨基)-2-(2,6-二氧代哌啶-3-基)异吲哚啉-1,3-二酮盐酸盐氧代哌啶-3-基)异吲哚啉-1,3-二酮盐酸盐 | 2446474-05-9 |
| VH 032 amide-alkylC3-acid | 5-(((S)-1-((2S,4R)-4-羟基-2-((4-(4-甲基噻唑-5-基)苄基)氨基甲酰基)吡咯烷-1-基)-3,3-二甲基-1-氧代丁烷-2-基)氨基)-5-氧代戊酸 | 2172819-73-5 |
| (S,R,S)-AHPC-C2-NH2 | (2S,4R)-1-((S)-2-(3-氨基丙酰胺基)-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺 | 2241643-69-4 |
| Pomalidomide-PEG3-C2-NH2 | 4-((2-(2-(2-(2-氨基乙氧基)乙氧基)乙氧基)乙基)氨基)-2-(2,6-二氧代哌啶-3-基)异吲哚啉-1,3-二酮 | 2093416-31-8 |
| Thalidomide-NH-C8-NH2 | 4-((8-氨基辛基)氨基)-2-(2,6-二氧代哌啶-3-基)异吲哚啉-1,3-二酮 | 1957236-36-0 |
| 4-((17-Amino-3,6,9,12,15-pentaoxaheptadecyl)amino)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione | 4-((17-氨基-3,6,9,12,15-五氧杂十七烷基)氨基)-2-(2,6-二氧代哌啶-3-基)异吲哚啉-1,3-二酮 | 2139329-71-6 |
| Thalidomide-4-O-C6-NH2 TFA | 4-((6-氨基己基)氧基)-2-(2,6-二氧代哌啶-3-基)异吲哚啉-1,3-二酮 2,2,2-三氟乙酸盐 | 1957235-99-2 |
| (S,R,S)-AHPC-C4-NH2 | (2S,4R)-1-((S)-2-(5-氨基戊氨基)-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺 | 2138439-53-7 |
| Thalidomide-NH-PEG1-NH2 | 4-((2-(2-氨基乙氧基)乙基)氨基)-2-(2,6-二氧代哌啶-3-基)异吲哚啉-1,3-二酮 | 2138439-12-8 |
| Pomalidomide-amino-PEG4-NH2 | 泊马度胺-四聚乙二醇-氨基 | 2331259-44-8 |
| Pomalidomide-C4-NH2 | 4-((4-氨基丁基)氨基)-2-(2,6-二氧代哌啶-3-基)异吲哚啉-1,3-二酮 | 1957236-34-8 |
| 4-((3-Aminopropyl)amino)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione 2,2,2-trifluoroacetate | 4-((3-氨基丙基)氨基)-2-(2,6-二氧代哌啶-3-基)异吲哚啉-1,3-二酮 2,2,2-三氟乙酸盐 | 2093388-21-5 |
| Thalidomide-NH-C4-NH2 TFA | 4-((4-氨基丁基)氨基)-2-(2,6-二氧代哌啶-3-基)异吲哚啉-1,3-二酮 2,2,2-三氟乙酸盐 | 2093387-50-7 |
| Thalidomide-NH-C6-NH2 | 4-((6-氨基己基)氨基)-2-(2,6-二氧代哌啶-3-基)异吲哚啉-1,3-二酮 | 2093386-50-4 |
| Pomalidomide-C2-NH2 | 4-((2-氨基乙基)氨基)-2-(2,6-二氧代哌啶-3-基)异吲哚啉-二酮 | 1957235-66-3 |
| Thalidomide-PEG2-C2-NH2 TFA | 沙利度胺-NH-PEG2-NH2 TFA | 2097509-36-7 |
| Pomalidomide-PEG1-C2-COOH | 3-(2-((2-(2,6-二氧代哌啶-3-基)-1,3-二氧代异吲哚啉-4-基)氨基)乙氧基)丙酸 | 2139348-60-8 |
| Thalidomide-O-amido-C8-NH2 TFA | N-(8-氨基辛基)-2-((2-(2,6-二氧代哌啶-3-基)-1,3-二氧代异吲哚啉-4-基)氧基)乙酰胺 2,2,2-三氟乙酸盐 | 1950635-16-1 |
| (S,R,S)-AHPC-PEG3-NH2 HCl | (2S,4R)-1-((S)-14-氨基-2-(叔丁基)-4-氧代-6,9,12-三氧杂-3-氮杂十四烷-1-酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 | 2097971-11-2 |